A kind of biological scaffold loaded with t-pa gene and preparation method thereof
A biological scaffold and gene technology, applied in the field of medical devices, can solve the problems of reduced thrombus formation rate, trauma, and accelerated atherosclerotic plaque formation, and achieve the effects of inhibiting SMC proliferation, preventing thrombosis, and preventing thrombosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] The invention provides a method for preparing a biological scaffold loaded with t-PA gene, comprising the steps of:
[0038]Step 1: Preparation of albumin nano solution: prepare albumin nano solution of t-PA gene plasmid with albumin and t-PA gene plasmid as raw materials;
[0039] Preparation of the coated stent: a. Prepare the stent surface coating liquid according to the ratio of 200 μg, 100 μg and 50 μg of type IV collagen, laminin and fibronectin per milliliter of hyaluronic acid;
[0040] b. After aseptic treatment, the stent is placed in the surface coating solution of the stent treated by ultrasonic oscillation. The conditions of the ultrasonic oscillation treatment are 40KHz, 50W, 40-60 minutes; after incubation at 25°C for 1 hour, no Bacteria were air-dried, and molded on a balloon with a diameter of 3 mm to obtain a coated stent;
[0041] Step 2: soak the coated stent obtained in step 1 in the albumin nano solution, incubate for 30-40min, and dry;
[0042] ...
Embodiment 2
[0052] The invention provides a method for preparing a biological scaffold loaded with t-PA gene, comprising the steps of:
[0053] Construction and expression of gene plasmids: Design 3 pairs of primers based on the three EST sequences and the t-PA gene sequence to amplify the three-break sequence of t-PA from the three EST cloning plasmids, and at the ends of the three pairs of primers respectively Introduced restriction sites. Three EST clones were amplified and cultured in LB medium containing ampicillin and chloramphenicol, and the three EST clone plasmids were extracted as templates for PCR amplification and three t-PA fragments were amplified, and the amplified products were recovered and sequenced for identification. Plasmid pSecTag2B and three t-PA fragments t-PA-1, t-PA-2, t-PA-3 were digested by HindIII and XhoI, HindIII and KpnI, KpnI and BamHI, BamHI and XhoI respectively, and purified by QIAGENPCRProductPurificationKit , T4 DNA ligase was ligated overnight at 14...
Embodiment 3
[0061] Embodiment 3 animal experiments
[0062] 1. Materials
[0063] 1.1 Animals: 18 purebred New Zealand white rabbits, male, weighing 2.3-2.5kg, provided by the Animal Center of Southern Medical University.
[0064] 1.2 Main reagents and instruments: plasmid pSecTag2B, competent cells E.ColiJM109, and Chinese hamster ovary cell lines were provided by Yaneng Biotechnology (Shenzhen) Co., Ltd.; restriction enzymes HindIII, KpnI, BamHI and XhoI were purchased from Bao Bioengineering Ltd.; VentDNA polymerase and T4DNA ligase were purchased from NewEngland Biolabs; rabbit anti-human t-PA polyclonal antibody, mouse anti-smooth muscle α-actin and PCNA monoclonal antibody, bovine serum albumin, t-PA ELISA detection kit Provided by Jingmei Bioengineering Co., Ltd. The ultrasonic generator is a product of Ningbo Xinzhi Biotechnology Co., Ltd.
[0065] 2 Animal models and scaffolding
[0066] 2.1 18 rabbits were randomly divided into two groups: experimental group (n=10) and contr...
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle size | aaaaa | aaaaa |
| polydispersity index | aaaaa | aaaaa |
| encapsulation rate | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 